IntroductionThese experiments were done to learn whether Mycoplasma pulmonis infections of the respiratory tract of rats can potentiate "neurogenic inflammation" and whether this potentiation is amplified by factors that exacerbate the infections. Pathogen-free F344 rats were inoculated intranasally with M. pulmonis or with sterile culture medium and then lived for 4 wk in an ammonia-free atmosphere or in air containing ammonia (100 parts per million "Neurogenic inflammation" is a type of inflammation mediated by substances released from sensory nerves (1, 2). Neurogenic inflammation in the mucosa of the respiratory tract is manifested by vasodilatation, increased vascular permeability with the extravasation of plasma proteins, diffusion ofextravasated plasma proteins into the airway lumen, adherence of leukocytes to the vascular endothelium, and secretion of mucus (3-8).Several factors can change the magnitude ofthe neurogenic inflammatory response. Transient reductions in the response can be produced by antagonists which block the action of substance P, a presumptive mediator of neurogenic inflammation (9), as well as by local anesthetics (3), 132-adrenergic agonists (5), xanthines (5), opioids (10), corticotropin-releasing factor (11), and glucocorticoids (12, 13). Alternatively, the neurogenic inflammatory response can be potentiated by inhibitors of neutral endopeptidase (EC 3.4.24.1 1 or enkephalinase), an enzyme which degrades the peptide mediators that produce neurogenic inflammation (14-16).Of potential clinical relevance, the magnitude ofthe neurogenic inflammatory response is altered by viral respiratory tract infections (17-19). For example, experimentally induced parainfluenza virus infections augment the contraction of airway smooth muscle induced by substance P and capsaicin, a sensory nerve stimulant (17, 18). The infections also potentiate the increase in vascular permeability evoked by capsaicin (19). These changes coincide with the peak of the viral infections, some 4-6 d after their onset.Neurogenic inflammation is also potentiated by naturally occurring respiratory tract infections due to a combination of organisms, including parainfluenza type I (Sendai) virus, coronavirus (sialodacryoadenitis virus/rat coronavirus), and Mycoplasma pulmonis (12,20). However, because ofits extraordinary magnitude and long ifnot permanent duration, the potentiation produced by these combined infections differs from that produced by transient viral infections.A first step toward understanding the mechanism of this long-lasting potentiation is determining which of the three organisms is responsible for the change. The protracted nature of the change and the characteristic pathological alterations in the airway mucosa point to the M. pulmonis infections (12,20